589 Phase I, Open-Label, Cohort Study of CAVATAK (Coxsackievirus A21) Given Intravenously to Stage IV Patients Bearing ICAM-1 Expressing Solid Tumours

Saved in:
Bibliographic Details
Title: 589 Phase I, Open-Label, Cohort Study of CAVATAK (Coxsackievirus A21) Given Intravenously to Stage IV Patients Bearing ICAM-1 Expressing Solid Tumours
Authors: Liauw, W., Chern, B., Shafren, D.R.
Source: European Journal of Cancer. Nov2012 Supplement, Vol. 48, p180-181. 2p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/S0959-8049(12)72386-9